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Neural tube defects (NTDs) include anencephaly, encephalocele 
and spina bifida (SB). Anencephaly is a lethal condition, whereas 
encephalocele and SB, which may cause long-term disability, are a 
considerable burden to families and the healthcare system,[1,2] and are 
relatively common birth defects. In South Africa (SA), studies give 
estimated population prevalence rates of 0.99 - 3.8 per 1 000 live-born 
infants.[3-6] 
Folic acid supplementation in the peri-conceptional period[7] or 
fortification of staple foods[8] has been shown to reduce the prevalence 
of NTDs. In SA, the introduction of folic acid fortification of maize 
and wheat products in 2003 was associated with a 31% reduction in 
NTD prevalence at sentinel sites, from 1.41 to 0.98/1 000 births.[9] 
Another preventive option is prenatal diagnosis by ultrasound, with 
the choice of termination of pregnancy (TOP), which has become 
increasingly available in parts of SA. Despite these changes, there are 
minimal data on NTD prevalence after 2003.
Effective surveillance of NTDs and other birth defects is important 
for various reasons, e.g. to establish burden of disease, monitor trends 
in birth prevalence, assess impact of preventive measures and detect 
outbreaks. The last role is highlighted by the recent link between 
maternal Zika virus infection and microcephaly in offspring,[10] and 
the possible link between maternal use of the antiretroviral drug 
dolutegravir and NTDs.[11] 
The National Department of Health (NDoH) has a population-
based birth defect surveillance system, which appears to be 
ineffective.[12] Hospital-based surveillance is an easier alternative, but 
less optimal because of lack of a defined denominator. It therefore 
works best where it captures most of the population of interest in 
a geographical region.[13] We anticipated this to be largely true in 
Western Cape Province, SA, for NTDs, or at least for SB, given that 
both prenatal diagnosis and paediatric management are centralised 
at tertiary hospitals with defined catchment areas. Furthermore, 
most NTDs are readily visible at birth. We therefore aimed to assess 
the detection of NTDs at a tertiary hospital using a range of prenatal, 
perinatal and postnatal data sources, and to estimate the impact of 
prenatal diagnosis and birth prevalence for the referral area. 
Methods
The study was conducted at Tygerberg Academic Hospital (TAH), a 
tertiary public hospital in the Western Cape. It is a referral centre for 
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approximately half of the province, including the eastern half of the 
Cape Town metropole (urban) and small towns and farms up to 300 km 
distant (rural). 
The Western Cape DoH mandates that, as far as possible, all 
pregnant women have access to an ultrasound assessment for fetal 
anomalies if they initiate care before 24 weeks’ gestation. In most 
cases, this is provided by sonographers at level 1 and 2 health 
facilities or mobile units. If a fetal anomaly is detected, the patient 
is referred to TAH for expert ultrasound assessment, non-directive 
genetic counselling and further management. This may include TOP, 
which is available for nearly all NTDs until 24 weeks’ gestation, and 
thereafter only if the prognosis is considered to be very poor. If born 
outside TAH, live-born infants with NTDs from the same catchment 
area are similarly referred to TAH for neurosurgical management, 
unless treatment is considered futile. 
Data regarding NTDs seen at TAH were collected retrospectively 
for 6 years in the post-fortification era (2003, 2004, 2007, 2009, 2011 
and 2012), for which multiple data sources were available. NTDs were 
classified as: anencephaly (with or without SB), encephalocele (with 
or without SB), and SB with intact cranium. Data were obtained from 
5 sources to maximise case ascertainment: the Fetal Medicine Unit 
(FMU) database, stillbirth assessment records for TAH, register of the 
neonatal intensive care unit (NICU), Perinatal Problem Identification 
Program (PPIP) and registers of the emergency and neurosurgical 
theatres. All 5 data sources were available for all 6 years assessed. 
The FMU database is a bespoke software system, Astraia (Astraia 
software gmbh, Germany), where clinical data, ultrasound findings 
and management plans are documented prospectively during 
actual antenatal visits, and used for clinical communication. The 
information in the database is therefore a prospective record of all 
NTD patients seen prenatally at TAH. 
Permission was obtained to access the PPIP database for TAH, 
which collects data for perinatal deaths (stillbirths with birth -
weight >500 g, or deaths before 1 week of age) as part of a 
national surveillance system of perinatal deaths. The programme is 
championed by an interested staff member, and data are prospectively 
gathered and linked to a weekly morbidity and mortality meeting 
attended by obstetricians, neonatologists, medical geneticists 
and pathologists. It provides quite accurate and comprehensive 
information on all perinatal deaths of infants delivered at TAH. 
Data on intrauterine deaths (IUDs) were obtained from the 
stillbirth assessment records of the Tygerberg Hospital Clinical Unit 
of Medical Genetics and Genetic Counselling. It is policy that all IUD 
fetuses at TAH be kept for inspection by a medical geneticist. Fetuses 
are also referred from other facilities in the metropolitan catchment 
area if the staff note an anomaly. The records contribute to PPIP 
data, but also include fetuses weighing ˂500 g (often the result of a 
medical TOP). 
Lastly, registers of the NICU and emergency and neurosurgical 
theatres were retrospectively reviewed for the entire study period. 
It was impossible to identify postnatally diagnosed cases, where 
patients were admitted to the general neonatal wards but did not 
undergo surgery, as this information is not routinely captured.
Cases originating from different sources were carefully cross-
checked to exclude duplication. 
In addition to the 6-year comparative review, the FMU database 
was used to assess the offer and uptake of TOP for a 10-year period 
(2003 - 2012), as it is nearly a complete representation of all prenatally 
diagnosed cases in the drainage area. The only exceptions could have 
been cases with unequivocal diagnosis of anencephaly at one of the 
two regional hospitals (although these are usually referred to TAH). 
Timing of TOP was considered ‘late’ if it occurred after 24 weeks of 
gestation, as TOP would then often involve a feticide procedure and 
policy therefore is more restrictive. 
For all prenatally detected cases, information regarding TOP or 
fetal demise was obtained from Astraia or maternal records. Where 
available, hospital records of all live-born infants were reviewed to 
assess whether the child died in hospital or was discharged alive. 
To estimate NTD prevalence in the referral area, denominator data 
for live births in all health facilities were obtained from the Western 
Cape DoH. These records include all births at healthcare facilities, or 
before arrival at the facility, and allowed separation between rural and 
urban births. Place of residence for cases of NTD (the numerator) 
was determined from hospital records. Due to changes in referral area 
over time, estimation of prevalence was only possible for 2011 - 2012.
Statistica 12.0 software (StatSoft, USA) was used to provide 
descriptive data and comparisons based on maternal and lesion 
characteristics. A univariate analysis of the data was conducted, with 
p<0.05 considered statistically significant. 
Ethical approval
Institutional Review Board approval for the study was granted by 
the Health Research Ethics Committee of Stellenbosch University 
(ref. no. S13/06/064). This included a waiver of informed consent 
for all participants. To maintain confidentiality of data, the study 
database was de-identified and password protected. 
Results
During the 6 years that data from all 5 sources were available, a total 
of 195 cases of NTD were identified. These included 59 (30%) cases 
of anencephaly, 28 (14%) of encephalocele and 108 (55%) of SB, of 
which 52, 25 and 61, respectively, had been detected prenatally (with 
an 8% incidence of twinning). Nine patients with anencephaly and 1 with 
encephalocele also had SB. 
The number of cases identified per year was quite variable, but 
with no identifiable temporal trend (Fig. 1). The proportion detected 
prenatally varied from a low of 55% in 2003 to a peak of 85% in 2009. 
There was a non-significant trend towards improvement in prenatal 
detection over time (r=0.56; p=0.25). 
Across the 5 data sources a total of 340 NTD identifications was 
made, with significant overlap between the sources. Of the 195 cases, 
29 (15%) were identified by 3 sources, 87 (45%) by 2 sources, and 
79 (41%) by a single data source. Fig. 2 shows the number of cases 
identified per source, and the number identified only by that source. 
The largest single contributor was the FMU database (138/195; 71%). 
This also contributed the largest number of unique single-source 
identifications (46 cases; 24% of all cases; and 58% of cases identified 
by a single source), while the PPIP database contributed no unique 
cases (Fig. 2). Retrospectively collected data from the registers of 
the NICU and theatres contributed 47 (24%) cases that were not 
otherwise identified.
The accuracy of ultrasound diagnosis in the FMU was assessed 
for 92 patients seen both prenatally and postnatally. Prenatal 
detection occurred in all 50 cases of confirmed cranial defects, 
and in 41 of 42 with SB (sensitivity 97.6%; 95% confidence interval 
(CI) 86.6 - 99.9). All 41 prenatally detected cases were confirmed 
postnatally (positive predictive value 100% (95% CI 92.6 - 100). 
The single false-negative scan was of a patient first seen at 35 weeks’ 
gestation with ventriculomegaly, and visualisation was affected 
by late gestation, supine fetal position and anhydramnios due to 
bilateral renal pathology.
Evidence of syndromic features or a specific underlying cause 
was found in 17% (34/195) of cases, including 17% (10/59) of 
anencephaly, 43% (12/28) of encephalocele and 11% (12/108) of 
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SB (p<0.001). The most frequently detected 
causes were amniotic bands (6%; 11/195) 
and chromosomal abnormalities (2%; 4/195), 
while 6% (11/195) were assigned as having 
‘multiple congenital anomalies’ due to 
the presence of anomalies in other organ 
systems, or multiple dysmorphic features. 
Table 1 describes outcomes up to dis-
charge (either dead or alive), which were 
known for 94% (184/195) of cases. Of the 
184 NTD patients with known outcome, 41% 
(75/184) were born alive and 31% (57/184) 
discharged alive. For SB, corresponding fig-
ures were 57% (59/103) and 50% (52/103), 
respectively. Of the 57 survivors who were 
discharged from hospital, 41 cases (72%; 3 with 
encephalocele and 38 with SB) had not been 
detected prenatally. Of the 109 fetuses that 
were not born alive, TOP was done in 92 (84%), 
and IUD occurred in 17 (16%).
Of the 195 cases, 138 (71%) were prenatally 
diagnosed, and 92 (47%) received TOP. Both 
prenatal diagnosis and TOP occurred less 
frequently for SB than for cranial defects 
(p<0.001). 
Antenatal management decisions were 
assessed in detail, using the full 10-year 
(2003 - 2012) dataset of 229 prenatally 
detected cases. TOP was offered to 87% of 
women, including 99% with a diagnosis before 
24 weeks’ gestation – the one exception being 
an anencephaly with a healthy co-twin – 
and 67% after 24 weeks’ gestation (Table 2). 
Eighteen (9%) of the 199 women who were 
offered TOP were lost to follow-up, but 
78% of the remaining 181 accepted TOP 
(71% overall TOP acceptance if all lost to 
follow-up cases would have opted against 
TOP). For all NTDs collectively, none of 
the following factors was associated with 
choice of TOP: urban or rural residence 
(p=0.42), diagnosis in the first or second 
half of the study period (p=0.96), age >37 or 
˂37 years (p=0.49), sonographic appearance 
of syndromic features (p=0.71), or diagnosis 
before or after 24 weeks’ gestation (p=0.35). 
Uptake of TOP was high for all lesions 
before 24 weeks’ gestation, but late TOP was 
less frequent for cases of SB than cranial 
lesions. Compared with ˂24 weeks, late TOP 
for SB was much less common (odds ratio 
(OR) 0.10; 95% CI 0.04 - 0.26; p<0.001), 
because TOP was much less frequently 
offered (51% (23/45) v. 100% (74/74); p<0.001) 
and perhaps less often accepted (57% (12/21) 
v. 78% (50/64); p=0.06).
The minimum birth prevalence of NTDs 
(cases per 1 000 live births) in the TAH 
catch ment area was estimated for 2011 and 
2012. During this period, there were 76 cases 
of NTDs and 93  609 live births. As at least 
71 but probably 75 women resided in the 
drainage area, the minimum overall NTD 
birth prevalence estimate was 0.76/1 000 
(95% CI 0.59 - 0.96) and the maximum 
estimate 0.80/1 000 (95% CI 0.63 - 1.00), 
similar for rural and urban areas. 
Estimated birth prevalence for urban and 
rural areas differed significantly according to 
NTD type (Table 3). For cranial lesions, the 
estimated birth prevalence was higher in urban 
areas, but for SB it was twice as high in rural 
than urban areas (0.47/1 000 (95% CI 0.28 - 
0.750) v. 0.23/1 000 (95% CI 0.12 - 0.40); 
p=0.05). 
Discussion
During 6 years of pre- and postnatal case 
ascertainment, the study identified nearly 
200 patients with NTDs first presenting to 
a tertiary hospital. This confirms that, while 
folic acid fortification may have had an effect, 
NTDs remain a substantial health problem. 
Lebese et al.[12] described cases reported to 
the NDoH birth defect surveillance system, 
and raised concerns about severe under-
ascertainment of cases. A comparison with 
our study lends weight to this: 195 new cases 
of NTDs were identified in 6 years (average 
of 33 cases/year) for a single tertiary hospital 
with its catchment area, including ˂5% of 
SA’s population and births. By comparison, 
the NDoH surveillance system detected 
787 cases for an overlapping 9-year period 
(87 cases/year) from SA as a whole. Our 
study suggests that data available at tertiary 
hospital level are underutilised. 
All data sources contributed to case 
finding, with 41% of NTDs being identified 
only by a single source, and with unique 
single-source cases being contributed by 
4 of the 5 sources (Fig. 2). This indicates 
that optimal ascertainment needs data from 
prenatal, perinatal and postnatal sources. 
This applies not only to a retrospective 
study such as ours, but also to prospective 
hospital-based surveillance, and to other 
birth defects, even more so to defects that 
are less readily amenable to pre- or perinatal 
detection than NTDs. 
It is known that TOPs and early IUDs 
are very difficult to ascertain postnatally,[13] 
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but use of prenatal data allowed us to identify many such cases, with 
prenatal cases accounting for 71% of all NTDs, and 24% of cases 
being recorded only prenatally (Fig. 1). Failure to include prenatal 
data would thus have caused considerable underestimation of the 
true NTD prevalence. 
Stillbirth assessment records identified 23% of cases and the PPIP 
database 15%. Most of these overlapped with prenatally detected 
cases, but where prenatal data are not available, other sources assume 
importance. 
To assess detection at TAH, we also reviewed data from other 
health facilities in the catchment area participating in the PPIP and 
identified 83 cases – 55 urban and 28 rural. Of these, 30 were detected 
at TAH (29 prenatally, but most also by TAH stillbirth and PPIP 
records). Therefore, the additional PPIP data sources may increase 
Table 1. Final patient outcomes in the 6-year period with prenatal and postnatal case ascertainment
Total, n (%) Anencephaly, n (%) Encephalocele, n (%) Spina bifida, n (%)* p-value
Patients, total 195 59 (30) 28 (14) 108 (55)
Outcome known 184/195 (94) 54/59 (92) 27/28 (96) 103/108 (95) 0.52
Prenatally detected 138/184 (75) 52/59 (88) 25/28 (89) 61/108 (56) <0.001
Termination of pregnancy 92/184 (50) 38/54 (70) 18/27 (67) 36/103 (35) <0.001
Stillbirth 17/184 (9) 8/54 (15) 1/27 (4) 8/103 (8) 0.2
Live born 75/184 (41) 8/54 (15) 8/27 (30) 59/103 (57) <0.001
Proportion prenatally diagnosed 28/75 (37) 7/8 (88) 5/8 (63) 16/59 (27) 0.001
Discharged alive 
    As % of live born  
57/184 (31)
57/75 (76)
0/54 (0)
0/8 (0)
5/27 (19)
5/8 (63)
52/103 (50)
52/59 (88)
<0.001
<0.001
Proportion prenatally diagnosed 16/57 (28) - 2/5 (40) 14/52 (27) 0.6
*Cases of intact cranium only.
Table 2. Offer and acceptance rates for pregnancy termination over a 10-year period
Total, n (%) Anencephaly, n (%) Encephalocele, n (%) Spina bifida, n (%) p-value
Patients, total 229 75 35 119
TOP offered 199/229 (87) 69/75 (92) 33/35 (94) 97/119 (82) 0.04 
TOP decision known 181/199 (91) 63/69 (91) 33/33 (100) 85/97 (88) 0.2
TOP after offered* 142/181 (78) 53/63 (84) 27/33 (82) 62/85 (73) 0.2
0.09†
Patients, n (<24 weeks) 140 46 20 74
TOP offered 139/140 (99) 45/46 (98) 20/20 (100) 74/74 (100) 0.5
TOP decision known 126/139 (91) 42/45 (93) 20/20 (100) 64/74 (87) 0.2
TOP after offered* 102/126 (81) 35/42 (83) 17/20 (85) 50/64 (78) 0.8
Patients, n (≥24 weeks) 89 29 15 45
TOP offered 60/89 (67) 24/29 (82) 13/15 (87) 23/45 (51) 0.004
<0.001†
TOP decision known 55/60 (92) 21/24 (88) 13/13 (100) 21/23 (91) 0.6
TOP after offered* 40/55 (73) 18/21 (86) 10/13 (77) 12/21 (57) 0.1
0.02†
Feticide 18/40 (45) 0/18 (0) 8/10 (80)  10/11 (91) <0.001
TOP = termination of pregnancy.
*Patients with known TOP decision. 
†p-value when comparing spina bifida with all cranial defects.
Table 3. Birth prevalence (NTD cases per 1 000 live births) by type and place of residence
Combined urban and rural* Urban* Rural* p-value
Live births, n 93 609 55 643 37 966
Anencephaly, n
Prevalence (95% CI)
27
0.29 (0.19 - 0.42)
21
0.38 (0.23 - 0.58)
6
0.16 (0.06 - 0.34)
0.05
Encephalocele, n
Prevalence (95% CI)
13
0.14 (0.07 - 0.24)
12
0.22 (0.11 - 0.38)
1
0.03 (0.0 - 0.15)
0.02
Spina bifida,†n 
Prevalence (95% CI)
31
0.33 (0.22 - 0.47)
13
0.23 (0.12 - 0.4)
18
0.47 (0.28 - 0.75)
0.05
All NTDs, n
Prevalence (95% CI)
71
0.76 (0.59 - 0.96)
46
0.83 (0.61 - 1.1)
25
0.66 (0.43 - 0.97)
0.4
NTD = neural tube defect; CI = confidence interval.
*Includes only patients known to reside in the Tygerberg Academic Hospital referral area.
†Patients with intact cranium only (cases of additional cranial defects were classified under cranial lesion).
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the total number of identifiable cases to as many as 248. It should 
be noted that the additional PPIP data did not include information 
on type of NTD and most likely included mainly anencephaly, did 
not provide full coverage of the rural catchment area, and could not 
always be easily assessed for duplication with TAH data. Therefore, 
we restrict ourselves to a discussion of TAH data, except where 
specifically indicated otherwise.
Of cases detected at TAH, live births comprised only a fraction 
(41% of all NTD and 57% of SB cases), with further attrition 
occurring by hospital discharge. Surveillance for NTDs that targets 
only live-born infants or patients attending outpatient clinics would 
therefore give a severe underestimate of the true birth prevalence. 
Comparison of prenatal and postnatal sources shows that 
sonographic detection of NTDs in the FMU was very accurate, with 
all cranial defects and all but one case of SB being detected. The 
sensitivity for detection of SB was similar to that quoted for expert 
centres.[14] 
The overall prenatal detection rate for NTDs, however, was only 
71%. This is lower than the 80 - 100% reported from countries with 
well-resourced fetal medical services,[15-17] yet probably very high by 
SA’s public health system standards, as the FMU at TAH has a well-
established network of sonographers at primary and secondary care 
levels. This gives access to ultrasound screening for pregnant women 
who initiate antenatal care before 24 weeks’ gestation throughout the 
TAH drainage area. Referral pathways to tertiary care are also well 
established. 
Maternal records were not available for postnatal patients delivered 
elsewhere; hence, we were unable to determine why a prenatal 
diagnosis was not made. It is probably owing to a combination of 
lack of prenatal ultrasound screening (possibly due to late booking 
or staff-related omissions) or false-negative examinations (possibly 
due to lack of experience or excessive case load of sonographers, 
combined with high levels of obesity in the population). These 
reasons warrant further study and continued education of both staff 
and women to optimise use of the Western Cape policy that offers a 
detailed ultrasound scan for all women at 19 - 22 weeks of gestation.
This study found a relatively high rate of TOP for prenatally 
detected NTDs – 70% for cranial lesions and 56% for SB. However, 
this represented only 35% of all SB cases – a discrepancy that relates 
in part to 29% not receiving prenatal diagnosis at their local facility. 
Further points emerged from the 10-year prenatal data (Table 2). 
TOP decisions were unknown for 9% of NTD (12% of SB) cases, 
which may cause over- or underestimation of the TOP rate. Before 
24 weeks’ gestation, the acceptance rate for TOP was 73 - 80% for 
all NTDs (depending on whether none or all cases with missing 
outcomes had TOP) with figures for SB being 68 - 81%. Given that 
the counselling provided was non-directive, this suggests a high 
degree of acceptability of early TOP for NTDs. 
Diagnosis of SB after 24 weeks’ gestation reduced the proportion 
of patients who were offered TOP by half, and perhaps acceptance 
of TOP by >25% (Table 2). A similar effect has been described in a 
developed country.[18] The need to offer feticide with late TOP has 
practical and emotional implications for both staff and patients, and 
means that regional policy guidelines restrict late TOP to patients 
with specific poor prognostic features. The problem is magnified by 
~40% of prenatal SB diagnoses being late.
The estimated birth prevalence for NTDs in our study was 0.76 - 0.80 
per 1 000 live births (anencephaly 0.29/1 000 (95% CI 0.19 - 0.42) and 
SB 0.33/1 000 (95% CI 0.22 - 0.47) ) (Table 3). Adding PPIP data from 
outlying institutions increased the estimated prevalence of NTDs to 
0.94/1 000 (1.02/1 000 urban; 0.82/1 000 rural). These estimates can 
be compared only cautiously with those in previous studies, because 
of differences in study design and ascertainment. A prospective 
study of the effect of folic acid fortification found a post-fortification 
prevalence of NTDs of 0.98/1 000 births (anen cephaly 0.37/1 000; 
SB 0.54/1 000) in a mixed urban and rural population, but in other 
regions of SA.[9] The last published data from Cape Town were 
before the introduction of folic acid fortification, and gave an NTD 
prevalence of 0.95 - 1.05/1 000 live births for populations similar to 
ours.[3,19]
The proportions of cranial and spinal lesions originating from 
urban and rural areas in this study suggest some underestimation, 
which is corroborated by the detection of additional lethal cases in 
PPIP data from outlying facilities. Specifically, we suspect that there 
was under-ascertainment of severe cranial lesions from rural areas, 
both pre- and postnatally, because such cases are easily recognised 
and may not have been referred to a tertiary level hospital. It is likely 
that PPIP data from outlying institutions do not fully capture this 
effect. In contrast, we expect the SB data to be relatively accurate, 
because the condition is usually associated with live birth (in the 
absence of TOP), is easily visible at birth and requires urgent neonatal 
surgery at a tertiary hospital.
Studies from the pre-fortification era indicate a higher birth 
prevalence of NTDs in rural than urban SA populations.[3-6,19] This 
accords with our finding that SB was twice as common in rural 
areas. If one assumes that our data for SB are accurate, and corrects 
the prevalence of cranial lesions accordingly, the true population 
prevalence of NTDs in the catchment area might be as high as 
1.18/1 000 live births. Although folic acid fortification may have had 
some effect on the prevalence, NTDs certainly remain a significant 
problem. As with birth defects and non-communicable diseases more 
generally, it can be predicted that their contribution to the burden of 
disease will increase over time.[20]
Taken together, the findings suggest that we identified a substantial 
proportion of NTD patients, especially with SB, born in the TAH 
catchment area. This is perhaps surprising, given that ours was a 
retrospective and hospital-based study, and is indicative of good 
record-keeping at the hospital. The data also suggest that hospital-
based prospective surveillance, even if limited to tertiary hospitals, 
should be useful if care is taken with data collection and multiple data 
sources are used. Depending on the quality of PPIP data at outlying 
health facilities, this may add to the completeness of the picture 
obtained at tertiary level. This approach is less resource and labour 
intensive than population-based surveillance. 
Study strengths and limitations
The retrospective nature of the study is a limitation. However, the 
prenatal and stillbirth data for TAH are quite accurate, as these were 
collected prospectively by the fetal medicine and medical genetics 
groups. The postnatal data from the NICU and theatre registers were 
retrospectively collected and may be less complete, but nonetheless 
added significantly to the number of cases identified. This dataset is 
the optimal case ascertainment that can be achieved from routinely 
collected information at the hospital. 
The use of multiple data sources strengthened our study, and the 
majority of cases were corroborated by more than one source, with 
the risk of accidentally inflating the number of cases being minimised 
by careful cross-checking of the different sources. In particular, 
prenatal ascertainment and evidence for prenatal diagnosis were 
accurate, which was a strength, because TOP and early IUDs 
(contributing 56% of cases) are otherwise particularly difficult to 
ascertain postnatally.[13] 
As the study was based in a tertiary hospital, caution should 
be observed in extrapolating the findings to the population as a 
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whole. Review of PPIP data from outlying facilities suggests that 
incorporating this information may increase detection by >20%. 
Another potential source of data loss is the provision of treatment, 
either prenatally or postnatally, at tertiary facilities outside the 
referral area. However, the existing referral pathways and experience 
of colleagues in the fetal medicine and neurosurgical services suggest 
that this is uncommon. 
The relative prevalence rates for the different NTDs helped to 
identify potential gaps in the data. These may be biased towards 
urban cases and less severe anomalies, as cases considered to be 
lethal (whether diagnosed prenatally or at birth) were probably not 
always referred to TAH, especially not from remote rural areas. Lack 
of identification of lethal cases from rural areas also means that the 
proportion of NTDs detected prenatally is somewhat overestimated. 
Conclusions
NTDs are important birth defects that are key targets for both 
surveillance and prenatal diagnosis. We used 5 data sources to 
identify NTDs at a tertiary hospital over 6 years, identifying a 
substantial number of cases. 
Information about facility-based surveillance is important because 
it is simpler than a population-based approach. Facility-based 
surveillance is becoming more feasible in the Western Cape for 
two main reasons: (i) the patient number is now a unique identifier 
issued at birth and used in all facilities across the province; and 
(ii) numerous clinical databases using the patient number are being 
linked. Our findings show that much data about NTDs are readily 
available at tertiary hospitals, even though these may not currently 
be collected as routine data. We also show the need to use multiple 
data sources covering the prenatal, perinatal and postnatal periods, 
and show the relative importance of individual sources in our setting. 
The addition of PPIP data from other facilities in the catchment 
area increases detection, but collection of data needs to be better 
harmonised between sites. 
We estimated the minimum NTD birth prevalence for the 
catchment area population to be 0.76 - 0.80/1 000 live births using 
TAH data, and up to 0.94/1 000 if including lethal defects from all 
facilities that collect PPIP data in the catchment area. Both estimates 
are probably lower than the true prevalence, given the differential 
case ascertainment from rural and urban areas for SB compared with 
anencephaly or (large) encephalocele. Based on our data, it remains 
possible that the prevalence has not substantially decreased with the 
introduction of folic acid fortification of food.
Of SB cases ascertained pre- or postnatally, 57% of infants were 
born alive and 50% discharged alive but nearly three-quarters of 
survivors had not been diagnosed prenatally. Women who were 
diagnosed prenatally before 24 weeks’ gestation were nearly always 
offered TOP and, for all types of NTD, the majority opted for the 
procedure after non-directive counselling. Later prenatal diagnosis 
was associated with much lower TOP rates for SB, because the option 
was much less often offered and perhaps also less often accepted. 
In this region, a relatively high proportion of NTDs are diagnosed 
prenatally. We show that a regional prenatal ultrasound programme, 
predominantly based in primary care but with ready access to a 
tertiary centre, can be quite effective. There is a need to optimise 
access to timeous detailed fetal anomaly scanning of high quality.
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